Société Cellectar Biosciences Inc Nasdaq
Actions
US15117F2039
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 65 | 15/06/15 |
Chad Kolean
DFI | Director of Finance/CFO | 59 | 28/05/14 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/23 |
Jarrod Longcor
COO | Chief Operating Officer | 51 | 15/07/16 |
Shane Lea
PRN | Corporate Officer/Principal | - | 21/11/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 07/04/17 |
Douglas Swirsky
CHM | Chairman | 54 | 07/04/17 |
John Neis
BRD | Director/Board Member | 68 | 01/02/08 |
James Caruso
CEO | Chief Executive Officer | 65 | 15/06/15 |
Stefan Loren
BRD | Director/Board Member | 60 | 15/06/15 |
Director/Board Member | 55 | 24/06/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 238 | 0 | 0 | 90,91 % |
Action B | 0 | 111 | 0 | 0 | |
Action C | 1 | 35 848 924 | 32 591 316 ( 90,91 %) | 0 |
Coordonnées société
![Adresse Cellectar Biosciences Inc](https://cdn.zonebourse.com/static/address/17516065.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+56,78 % | 848 Md | |
+33,06 % | 627 Md | |
-0,36 % | 363 Md | |
+15,50 % | 318 Md | |
+12,33 % | 299 Md | |
+14,96 % | 243 Md | |
+16,98 % | 225 Md | |
+16,20 % | 179 Md | |
+4,52 % | 167 Md |
- Bourse
- Actions
- Action CLRB
- Action
- Société Cellectar Biosciences Inc